macular degeneration

Home/Tag: macular degeneration

Eye implant made from stem cells could halt macular degeneration

Age-related macular degeneration (AMD) is one of the leading causes of blindness, affecting more than 10% of people over age 65 in developed countries. Drugs like Roche’s Lucentis, which plugs up leaky blood vessels in the eye that are characteristic of the “wet” form of the disease, can help, but there’s still a demand for

Macular degeneration linked to aging immune cells

As people age, their immune systems age, too. And new research at Washington University School of Medicine in St. Louis suggests that aging immune cells increase the risk for age-related macular degeneration, a major cause of blindness in the United States. Studying mice and cells from patients, the researchers found that as immune cells called

Some Stem Cells Are Rejected, Some Aren’t, Says iPSC Work

Wed, 10/21/2015 - 9:38am Cynthia Fox, Science Writer Embryonic stem (ES) cell-like stem cells made from adult cells—and morphed into eye cells—are not rejected by the immune system, according to “humanized mouse” data in Cell Stem Cell. Coming alongside news that the first UK macular degeneration patient received eye cells made from normal ES cells,

Vitamin D may play key role in preventing macular degeneration

Amy Millen, associate professor of epidemiology and environmental health in the University at Buffalo's School of Public Health and Health Professions, is lead author on a paper published Aug. 27 in JAMA Ophthalmology. UB research shows women with two risk alleles and low D status are more likely to have the disease By David J.

New clues found to vision loss in macular degeneration​​​

August 11, 2015 By Jim Dryden APTE LABORATORY PHOTO In this image of the retina, normal blood vessels (green) surround a clump of new, abnormal vessels that has formed beneath the center of the retina. Scientists at Washington University School of Medicine in St. Louis have identified a molecular pathway that leads to the formation

Stem Cells Allow Nearly Blind Patients to See

Time Magazine, by Alice Park ~ October 14, 2014 Embryonic stem cells can be turned into a therapy to help the sight of the nearly blind In a report published in the journal Lancet, scientists led by Dr. Robert Lanza, chief scientific officer at Advanced Cell Technology, provide the first evidence that stem cells from

StemCells, Inc. to Discuss Plans for Advancing Clinical Studies in Spinal Cord Injury and Age Related Macular Regeneration

Globe Newswire, source: Stem Cells, Inc. ~ January 7, 2014 NEWARK, Calif., Jan. 7, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Eliseo Salinas, M.D., Executive Vice President and Head of Research and Development, will provide an update on the StemCells, Inc. development programs and translational work being done with the Company's proprietary

Cholesterol buildup links atherosclerosis and macular degeneration

April 2, 2013 - By Jim Dryden A new study raises the intriguing possibility that drugs prescribed to lower cholesterol may be effective against macular degeneration, a blinding eye disease. Researchers at Washington University School of Medicine in St. Louis have found that age-related macular degeneration, the leading cause of vision loss in Americans over 50, shares a

Doctor wins NIH prize for ideas to restore vision

February 11, 2013 By Jim Dryden A Washington University retina specialist is one of 10 U.S. scientists selected by the National Eye Institute (NEI), part of the National Institutes of Health (NIH), for innovative projects to improve or restore vision. The winning proposal from Rajesh C. Rao, MD, a vitreoretinal surgery fellow in the Department of

UNMC: Stem cell breakthrough builds hope for the blind

January 22, 2013 5:00 pm  •  By MARK ANDERSEN / Lincoln Journal Star Researchers at the University of Nebraska Medical Center on Tuesday announced a significant step in adult stem cell research that could take science closer to cures for glaucoma and age-related macular degeneration. A team led by Iqbal Ahmad, professor of ophthalmology and visual sciences,